Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
18
Frequently Asked Questions
What is Market Cap of Tevogen Bio Holdings Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tevogen Bio Holdings Inc. market cap is $172.96M.
What is the 52-week high for Tevogen Bio Holdings Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tevogen Bio Holdings Inc. 52 week high is $3.09 as of September 06, 2025.
What is the 52-week low for Tevogen Bio Holdings Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tevogen Bio Holdings Inc. 52 week low is $0.2556 as of September 06, 2025.
What is Tevogen Bio Holdings Inc. stock price today?
Tevogen Bio Holdings Inc. stock price today is $0.8664.
What was Tevogen Bio Holdings Inc. stock price yesterday?
Tevogen Bio Holdings Inc. stock price yesterday was $0.8793.
What is the PE ratio of Tevogen Bio Holdings Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tevogen Bio Holdings Inc.’s P/E ratio is -4.82.
What is the Price-to-Book ratio of Tevogen Bio Holdings Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tevogen Bio Holdings Inc. P/B ratio is -9.3146.
What is the 50-day moving average of Tevogen Bio Holdings Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tevogen Bio Holdings Inc. 50-day moving average is $1.06.
How many employess does Tevogen Bio Holdings Inc. has?